United States 119th Congress Status: In Committee 2 D cosponsors

HR 9703 — Improving Access to Transfusion Care for Hospice Patients Act of 2026

Last action — Referred to the House Committee on Ways and Means.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced July 15, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 18% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 2 sponsors

    1 primary, 1 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 D).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

This bill aims to enhance transfusion care for hospice patients.

The proposed legislation seeks to improve access to transfusion services specifically for patients in hospice care. It addresses the need for better healthcare support for individuals receiving end-of-life care.

What this means for you
  • Families: Families of hospice patients might experience increased reassurance knowing that transfusion care will be more accessible.
  • Healthcare: Hospitals and healthcare providers may need to adjust their practices to accommodate improved transfusion services for hospice patients.

Summary

Improving Access to Transfusion Care for Hospice Patients Act of 2026This bill requires the Center for Medicare and Medicaid Innovation (CMMI) to test a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under Medicare. The CMMI must evaluate the model by comparing patients participating in the model with those outside of the model in relation to specified metrics, such as hospital utilization and days of hospice care before the end of life.

Bill Text

How this bill changes current law

3 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill requires the Center for Medicare and Medicaid Innovation to test a model for separately paying for blood transfusions provided to hospice patients.

  • 42 U.S.C. 1315a

    The models selected under this subparagraph shall include the testing of the model described in subsection (h).

    It adds a requirement that the testing models include one specific to blood transfusions.

  • 42 U.S.C. 1315a

    Testing of Allowing Blood Transfusions To Be Paid Separately From the Medicare Hospice All-Inclusive Per Diem Payment.--(1) In general.--Not later than 1 year after the date of enactment of this subsection, the CMI shall establish and implement a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under section 1814(i). The separate payment amount for such blood transfusion shall be the amount that would otherwise apply under title XVIII if the transfusion was not furnished as part of hospice care.

    It establishes a new requirement for the CMI to develop a payment model for blood transfusions in hospice care.

  • 42 U.S.C. 1315a

    In conducting any evaluation of the model described in paragraph (1) pursuant to subsection (b)(4), the CMI shall ensure it compares participants under the model with similar patients outside of the model with respect to the following metrics: (A) The number of chemotherapy services furnished in the last 14 days of life. (B) Hospital utilization in the last 30 days of life, including emergency department visits, in-patient and observation status stays (including the length of the stays), and intensive care unit (ICU) days. (C) How many days receiving hospice care before the end of life. (D) The number of patients receiving hospice care who received a transfusion compared to patients with similar diagnoses not receiving hospice care. (E) The average frequency of transfusion for patients receiving hospice care compared to patients not receiving hospice care. (F) The number of transfusions for patients receiving hospice care compared to patients not receiving hospice care. (G) Other areas determined appropriate by the CMI.

    It adds specific evaluation metrics for assessing the new payment model regarding blood transfusions.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the House Committee on Ways and Means.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 545 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (545)

545 members have not signed on to this bill.

Show all 545 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

veterans healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 9703 do?
Improving Access to Transfusion Care for Hospice Patients Act of 2026This bill requires the Center for Medicare and Medicaid Innovation (CMMI) to test a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under Medicare. The CMMI must evaluate the model by comparing patients participating in the model with those outside of the model in relation to specified metrics, such as hospital utilization and days of hospice care before the end of life.
Who sponsors HR 9703?
HR 9703 is sponsored by Dingell, Debbie (Democratic) and Norton, Eleanor Holmes (Democratic).
What is the current status of HR 9703?
This bill is in committee in the House. Introduced July 15, 2026. It must pass committee before a floor vote.
Where can I track HR 9703?
Track HR 9703 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 9703

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 9703

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →